The impact of METTL3 on bladder cancer through m6A modification: a potential therapeutic target and prognostic biomarker

QR Code

The impact of METTL3 on bladder cancer through m6A modification: a potential therapeutic target and prognostic biomarker

Bladder cancer (BCa) is one of the most prevalent malignant tumors globally, particularly among men. According to data from the Global Cancer Research Agency, the annual incidence of BCa continues to rise, and its clinical features are complex, involving various molecular mechanisms and pathophysiol...

Full description

Saved in:

Bibliographic Details
Main Authors:	Dong Wen, Pengcheng Fu, Geliu Shuai, Yuebin Wang, Shengxin Yu, Huiquan Liu, Wei Wan, Junrong Zou, Xiaofeng Zou
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-07-01
Series:	Frontiers in Oncology
Subjects:	m6A METTL3 bladder cancer bladder cancer treatment bladder cancer drug resistance bladder cancer prognosis
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1622117/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Identification and Evaluation of the Urinary Microbiota Associated With Bladder Cancer
by: Nannan Li, et al.
Published: (2025-08-01)

Prognostic markers of urinary bladder cancer lymphatic spread
by: V. N. Pavlov, et al.
Published: (2012-04-01)

Development and validation of nomograms for predicting prognosis in patients with resectable bladder urothelial carcinoma undergoing radical cystectomy: a multicenter retrospective study
by: Junjie Ji, et al.
Published: (2025-07-01)

TREATMENT OF NON-MUSCLE-INVASIVE HIGH-RISK BLADDER CANCER
by: S. A. Ivanov, et al.
Published: (2017-07-01)

High expression of mitosis-related gene CCDC14 could predict a better prognosis for bladder cancer patients
by: Haojie Dai, et al.
Published: (2025-08-01)

From dysbiosis to precision therapy: decoding the gut-bladder axis in bladder carcinogenesis
by: Ze-qiang Liu, et al.
Published: (2025-07-01)

The role of immunohistochemical analysis in determining the molecular subtypes of bladder cancer
by: M. V. Berkut, et al.
Published: (2024-12-01)

Comparison of thulium and holmium lasers with conventional transurethral bladder resection for non-muscle invasive bladder cancer
by: S. V. Popov, et al.
Published: (2024-07-01)

Electromyographic features of the perineum and pelvic floor in patients with an artificial bladder
by: R.V. Savchuk, et al.
Published: (2021-09-01)

Molecular genetic subtypes of non-muscle-invasive bladder cancer: their impact on disease prognosis
by: Sh. M. Sargsian, et al.
Published: (2025-07-01)

EMBOLIZATION FOR HEMORRHAGE IN PATIENTS WITH BLADDER CANCER
by: S. A. Prozorov, et al.
Published: (2018-01-01)

Multimodal Approach to Imaging and Staging of Bladder Cancer: Diagnostic Standards and Future Trends
by: A. Sh. Kagarmanova, et al.
Published: (2024-12-01)

TRANSURETHRAL EN BLOCK RESECTION OF THE BLADDER WALL TUMOR
by: М. Yu. Ulyanin, et al.
Published: (2016-02-01)

Clinical and morphological features of bladder cancer course in HPV-infected patients
by: A. A. Pulatova, et al.
Published: (2023-09-01)

Molecular genetic subtypes of bladder cancer
by: S. V. Kotov, et al.
Published: (2023-10-01)

Definite total radical resection in treatment of patients, suffering low-differentiated cancer of the bladder
by: P. G. Yakovlev
Published: (2020-12-01)

СHANGES IN PARAMETERS OF LUMINOL-DEPENDENT AND LUCIGENIN-DEPENDENT CHEMILUMINESCENCE OF PERIPHERAL BLOOD NEUTROPHILS IN PATIENTS WITH BLADDER CANCER IN THE DISEASE DYNAMICS
by: L. M. Kurtasova, et al.
Published: (2015-04-01)

Early postoperative versus delayed radiotherapy in bladder sparring treatment of patients with high-grade urinary bladder cancer
by: P. G. Yakovlev
Published: (2020-10-01)

Urine microbiota in non-muscle-invasive bladder cancer and approaches to its detection
by: M. I. Kogan, et al.
Published: (2024-07-01)

Local immunity features in patients with non-invasive muscular bladder cancer of various degrees of malignance
by: A. B. Sagakyants, et al.
Published: (2022-12-01)

Results of chemoradiotherapyfor muscle-invasive bladder cancer
by: Yu. V. Gumenetskaya, et al.
Published: (2016-02-01)

Impact of regular cystoscopy on prognosis in non–muscle-invasive bladder cancer: A nationwide study
by: Jeong-Soo Kim, et al.
Published: (2025-07-01)

Dysregulation of the Coagulation System in Patients with Prostate and Bladder Cancer
by: G. A. Konstantinova
Published: (2011-12-01)

EPIDEMIOLOGICAL ASPECTS THE INCIDENCE OF CANCER OF THE KIDNEY AND BLADDER IN PRIMORSKY KRAI
by: G. N. Alexeyeva, et al.
Published: (2017-03-01)

Bladder metastasis from primary breast cancer: a case report
by: Kimiyasu Yoneyama, et al.
Published: (2018-07-01)

ROLE OF HIGH-FIELD MAGNETIC RESONANCE IMAGING IN DIAGNOSIS OF BLADDER CANCER (LITERATURE REVIEW)
by: Е. G. Grigoryev, et al.
Published: (2016-02-01)

Intravesical Therapy of Superficial Urothelial Bladder Cancer with BCG and Epirubicin 50 Mg - Comparative Analysis
by: Boyan Atanasov, et al.
Published: (2022-06-01)

The role of herpes and human papillomavirus infection in prostate and bladder carcinogenesis
by: L. M. Mikhaleva, et al.
Published: (2022-01-01)

Long-term effect of treatment for non-muscle invasive bladder cancer on Quality of life: a cross-sectional study
by: Rikke Vilsbøll Milling, et al.
Published: (2025-07-01)

Single-surgeon outcomes of open radical cystectomy for muscle-invasive bladder cancer: Experience from a tertiary center in Azerbaijan
by: Rashad Sholan, et al.
Published: (2025-09-01)

Bladder cancer: issues requiring further research
by: I. A. Rozhkov, et al.
Published: (2024-09-01)

Significance of tumor-associated macrophages in bladder cancer development
by: V. N. Pavlov, et al.
Published: (2022-10-01)

The role of exosomes in bladder cancer immunotherapy
by: Mohammad Mousaei Ghasroldasht, et al.
Published: (2025-06-01)

UBC-test use in the capacity of urinary marker of bladder cancer
by: S. I. Vintizenko, et al.
Published: (2009-04-01)

Liquid Biopsy: Current advancements in clinical practice for bladder cancer
by: Felice Crocetto, et al.
Published: (2025-09-01)

Current capabilities of endoscopic diagnosis of non-muscle invasive bladder cancer
by: I. N. Zaborskii, et al.
Published: (2020-06-01)

NEOADJUVANT CHEMOTHERAPY WITH RADICAL CYSTECTOMY IN THE TREATMENT OF MUSCLE-INVASIVE BLADDER CANCER
by: N. S. Nurgaliev, et al.
Published: (2016-10-01)

Pseudocholinesterase levels and atherogenic indices as indicators of invasive and non-invasive bladder cancer
by: Hasan N. Smeasm, et al.
Published: (2025-07-01)

Recent advances in transurethral resection of bladder tumors
by: D. I. Babaevskaya, et al.
Published: (2022-04-01)

Comprehensive Pan-Cancer Analysis Identifies IGFL1 as an Oncogenic Biomarker and Immunotherapeutic Target with Experimental Validation in Bladder Cancer
by: Liang Z, et al.
Published: (2025-07-01)